- Home
- CCJ vs TAK Comparison
CCJ vs TAK Comparison
Compare CCJ & TAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CCJ | TAK |
|---|---|---|
| Founded | 1987 | 1781 |
| Country | Canada | Japan |
| Employees | N/A | N/A |
| Industry | Other Metals and Minerals | Biotechnology: Pharmaceutical Preparations |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 40.4B | 43.3B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | CCJ | TAK |
|---|---|---|
| Price | $92.76 | $15.64 |
| Analyst Decision | Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $114.38 | N/A |
| AVG Volume (30 Days) | ★ 3.2M | 2.5M |
| Earning Date | 11-05-2025 | 01-29-2026 |
| Dividend Yield | 0.18% | ★ 3.37% |
| EPS Growth | ★ 364.36 | N/A |
| EPS | ★ 0.87 | 0.14 |
| Revenue | $2,487,042,049.00 | ★ $29,846,840,032.00 |
| Revenue This Year | $10.40 | N/A |
| Revenue Next Year | $8.64 | $0.47 |
| P/E Ratio | ★ $107.02 | $112.32 |
| Revenue Growth | ★ 23.88 | N/A |
| 52 Week Low | $35.00 | $12.80 |
| 52 Week High | $110.16 | $15.69 |
Technical Indicators
Market Signals| Indicator | CCJ | TAK |
|---|---|---|
| Relative Strength Index (RSI) | 55.08 | 78.41 |
| Support Level | $84.29 | $14.43 |
| Resistance Level | $95.10 | $14.66 |
| Average True Range (ATR) | 3.61 | 0.17 |
| MACD | 0.35 | 0.13 |
| Stochastic Oscillator | 70.52 | 99.66 |
Price Performance
Historical ComparisonAbout CCJ Cameco Corporation
Cameco Corp is a provider of uranium needed to generate clean, reliable baseload electricity around the globe. one of those uranium producers. It has three reportable segments, Uranium, Fuel Services, and Westinghouse. It derives maximum revenue from the Westinghouse Segment. It has some projects namely; Millennium, Yeelirrie, Kintyre, and Exploration. The company operates in Canada, Kazakhstan, Germany, Australia, and the United States.
About TAK Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.6 trillion in fiscal 2024. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with over 50% derived from the US, 20% from Japan, 20% from Europe and Canada.